Congenital Adrenal Hyperplasia Panel, 11-Beta Hydroxylase Deficiency
Use
The Congenital Adrenal Hyperplasia Panel for 11-Beta Hydroxylase Deficiency is used to screen for this endocrine disorder which affects steroid production in the adrenal glands. It is particularly important for detecting issues early in life to manage symptoms and prevent complications associated with hormone imbalance. This test evaluates hormone levels in serum or plasma to assist in diagnosing and monitoring this condition.
Special Instructions
Collect specimens between 6-10 a.m. to ensure accurate measurement of hormone levels. Separate serum or plasma from cells within 2 hours of collection to maintain integrity. Transport specimens in a refrigerated state to ensure stability during transit.
Limitations
This test is a laboratory-developed test and has not undergone FDA clearance. The results should be interpreted in conjunction with other clinical data and assessments. Variability in hormone levels due to external factors, such as medication or hormonal therapies, may impact results. The test is not intended to be the sole method of diagnosis; further clinical evaluation is recommended where results are atypical.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 1657-6
- 1668-3
- 1854-9
- 2193-1
- 2986-8
Result Turnaround Time
1-8 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1.2 mL
Minimum Volume
0.7 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Collect blood between 6-10 a.m. in a serum separator or green top tube. Also acceptable: pink (K2EDTA) or plain red for serum.
Patient Preparation
Collect between 6-10 a.m.
Storage Instructions
Refrigerated.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 1 week |
| Frozen | 6 months |